GSK PLC (GSK)
36.97
+0.09
(+0.24%)
USD |
NYSE |
Nov 04, 16:00
36.98
+0.01
(+0.03%)
After-Hours: 20:00
GSK Total Liabilities (Quarterly): 59.68B for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 59.68B |
| June 30, 2024 | 56.03B |
| March 31, 2024 | 57.17B |
| December 31, 2023 | 58.87B |
| September 30, 2023 | 58.86B |
| June 30, 2023 | 59.66B |
| March 31, 2023 | 58.56B |
| December 31, 2022 | 60.57B |
| September 30, 2022 | 57.62B |
| June 30, 2022 | 80.54B |
| March 31, 2022 | 88.09B |
| December 31, 2021 | 77.96B |
| September 30, 2021 | 76.45B |
| June 30, 2021 | 76.72B |
| March 31, 2021 | 78.44B |
| December 31, 2020 | 81.26B |
| September 30, 2020 | 77.57B |
| June 30, 2020 | 79.40B |
| March 31, 2020 | 79.52B |
| December 31, 2019 | 80.42B |
| September 30, 2019 | 80.13B |
| June 30, 2019 | 76.88B |
| March 31, 2019 | 76.95B |
| December 31, 2018 | 69.02B |
| September 30, 2018 | 71.50B |
| Date | Value |
|---|---|
| June 30, 2018 | 71.40B |
| March 31, 2018 | 73.68B |
| December 31, 2017 | 71.48B |
| September 30, 2017 | 72.46B |
| June 30, 2017 | 70.01B |
| March 31, 2017 | 66.93B |
| December 31, 2016 | 66.48B |
| September 30, 2016 | 71.02B |
| June 30, 2016 | 71.89B |
| March 31, 2016 | 68.89B |
| December 31, 2015 | 66.03B |
| September 30, 2015 | 66.36B |
| June 30, 2015 | 68.51B |
| March 31, 2015 | 68.99B |
| December 31, 2014 | 55.59B |
| September 30, 2014 | 56.12B |
| June 30, 2014 | 54.53B |
| March 31, 2014 | 53.72B |
| December 31, 2013 | 56.52B |
| September 30, 2013 | 55.46B |
| June 30, 2013 | 53.07B |
| March 31, 2013 | 53.60B |
| December 31, 2012 | 56.15B |
| September 30, 2012 | 54.25B |
| June 30, 2012 | 53.78B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
56.03B
Minimum
Jun 2024
88.09B
Maximum
Mar 2022
70.17B
Average
76.59B
Median
Total Liabilities (Quarterly) Benchmarks
| AstraZeneca PLC | 64.74B |
| Pfizer Inc | 128.22B |
| Adaptimmune Therapeutics PLC | 225.43M |
| TC BioPharm (Holdings) PLC | 7.807M |
| Moderna Inc | 3.968B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 77.68B |
| Shareholders Equity (Quarterly) | 18.75B |
| Debt to Equity Ratio | 1.146 |
| Current Ratio | 0.8061 |
| Net Debt Paydown Yield | 1.34% |